Corporate news

Investigating inhibitor development in patients with Hemophilia A Lecture on state-of-the-art of the SIPPET Study presented by P.M. Mannucci, sponsored by Grifols, Kedrion and LFB
+ info

Grifols presents its GATRA scholarship program to promote research on antithrombin therapy The GATRA program (Grifols Antithrombin Research Awards) was announced on October 13, World Thrombosis Day, and grants two yearly scholarships of 50,000 euros each, for a 12-month period of research
+ info

Grifols reinforces its commitment to research in the 7th edition of the Martín Villar Awards for Research on Hemostasis Created in 2007, the awards recognize progress made in the field of Hemostasis. The awards are endowed with 20,000 euros for each of the two prizes: basic research and clinical research.
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

New transfusion medicine solutions

Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info


get to know us better